Iodine

Argentina

Vitamin A

 Iron Belize
     
MN Project Home Page Bookmarks
Country Index Epidemiological Data
Country Profile Policy & Legislation
Program Data
Monitoring
Program Resources

EPIDEMIOLOGICAL DATA
     
Clinical Vitamin A Deficiency
Most Recent Clinical VAD Survey - No recent clinical VAD survey.
Date:
Groups Surveyed:
Sample Size:
Sampling Method:
Sampling Strategy:
Estimated Prevalence of VAD: Presence of at least one of the following clinical indicators
1.  Conjunctival xeroxes with bitots spot
2.  Corneal xeroxes/ ulceration/ keratomalacia
3.  Corneal scar

 
 
Sub-clinical Vitamin A Deficiency
Most Recent Sub-clinical VAD Surveys - Sub-national survey
Date: Buenos Aires survey (NUTRIABA) in Nov-Dec 1999
Groups Surveyed: Children 0-60 months in age.
Sample Size: 449 children
Sampling Method: Three steps random sampling.
Sampling Strategy: First step was to randomly select 40 primary survey points.  Secondly, a random selection of 20 secondary survey points.  Lastly, a random selection of 30 children in every secondary survey point.
Estimated Prevalence of VAD: Indicator: serum retinol <0.7 mmol/L
 

Group

Sample Size

Population in Region

Prevalence in Sample

Estimated Population Affected *
Children 0-60 months 449 717,239 6.3%
Children 0-23 months 101 NR 7.9%
Children 24-60 months 348 NR 5.7%
NR: Not reported
 
Most Recent Sub-clinical VAD Surveys - Sub-national survey
Date: Chaco province survey in Oct-Nov 1998.
Groups Surveyed: Children 6-24 months in age and pregnant women
Sample Size: 440 pregnant women, 440 children 6-24 months
Sampling Method: Three steps random sampling.
Sampling Strategy: First step is to randomly select 44 areas from a list of all census areas in the province.  Second step is to randomly select 10 homes from a list of all homes with pregnant women and independent selection from homes with children 6-24 months.
Estimated Prevalence of VAD: Indicator: serum retinol <0.7 mmol/L
 

Group

Sample Size

Population in Region

Prevalence in Sample

Estimated Population Affected *
Children 6-24 months 399 33,000 5.3%

 
     
 

POLICY AND LEGISLATION
 

Legislation on VAD
    There is no VAD legislation in Argentina and it is neither being developed or about to be enacted.
 

Government Agency to Address VAD

     Currently, there is no government agency that deals with VAD in the country.
 
     

PROGRAM DATA
Supplementation - No VA supplementation programs.
 

Fortification
    

There are no VA fortification programs
Other Programs - No other programs relating to VAD.
     
     
 
MONITORING
 

Clinical and Sub-clinical VAD
     Monitoring activities were not reported.
 
Supplementation
     There are no supplementation programs to monitor.
Fortification
     There are no fortification programs to monitor. 
     
     
PROGRAM RESOURCES
   
Donor Agencies - Not reported
 
VAD Program Funding History and Projections -  Not reported